Who We Are Addepar is a global data and AI platform empowering investment professionals to turn complex financial information into actionable intelligence. Addepar unifies portfolio, market and client data in a total portfolio view and delivers
Work Your Magic with us! Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe love innovating with science and technology to enrich
About the role We’re looking for a hardworking, driven individual with superb energy, passion and initiative for new business acquisition. The Enterprise Account Executive role focuses exclusively on formulating and executing a sales strategy within an assigned
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
About the Role Neural Concept is building the future of AI-powered engineering software, and our CTO is at the heart of that mission. As an Assistant to the CTO, you will be the operational backbone that
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Blockstream was founded in 2014 by Dr. Adam Back and a group of fellow cryptographers and engineers who are passionate about Bitcoin and its potential to change the world. Today, Blockstream is the leading Bitcoin company,
Blockstream was founded in 2014 by Dr. Adam Back and a group of fellow cryptographers and engineers who are passionate about Bitcoin and its potential to change the world. Today, Blockstream is the leading Bitcoin company,
Blockstream was founded in 2014 by Dr. Adam Back and a group of fellow cryptographers and engineers who are passionate about Bitcoin and its potential to change the world. Today, Blockstream is the leading Bitcoin company,
Blockstream was founded in 2014 by Dr. Adam Back and a group of fellow cryptographers and engineers who are passionate about Bitcoin and its potential to change the world. Today, Blockstream is the leading Bitcoin company,
Blockstream was founded in 2014 by Dr. Adam Back and a group of fellow cryptographers and engineers who are passionate about Bitcoin and its potential to change the world. Today, Blockstream is the leading Bitcoin company,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
The Bachem Group is planning a future site in Sisslefeld in Northwestern Switzerland. As part of Bachem’ s long-term strategy, the planned site is expected to strengthen the company’s global manufacturing network and to expand future
Mandarin Oriental Savoy, Zurich is looking for a Sales & Marketing Trainee to join our Sales & Marketing team! Are you a master of craft? Do you thrive in a team that succeeds together, demonstrating integrity
Work ScheduleStandard Office Hours (40/wk) Environmental ConditionsOffice Job Description At Thermo Fisher Scientific, each one of our 100,000+ colleagues has a unique story to tell. Join us and contribute to our singular mission—enabling our customers to
The Director, Clinical Operations Program Leadership (COPL) is responsible for leading the strategy, planning and implementation of clinical development program operations in the Clinical Trial Delivery Unit of the Quantitative Science Development Operations organization (QSDO). The
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Oettinger Davidoff Group, with sales of over half a billion Swiss francs and over 4,000 employees around the world, traces its roots back to 1875 and remains family-owned to this day. The company is dedicated to
Job Description The greatest inventions would not be brought to market without the right project management and administrative support. Woven into every part of the organization, our Administrative teams makes sure our concepts become reality. The